Back to Terrain Console
SAMe consumer
DAO/ABP1 Histamine-Clearance Terrain
Histamine-clearance context with contested symptom-mapping boundaries.
Evidence quality visible
No dosing or treatment advice
Terrain context linked
What The Enzyme Does
DAO/ABP1 is represented as review-required histamine-clearance context. Symptom mapping is treated as contested until approved evidence supports it.
- Gene
- Diamine oxidase / amiloride binding protein 1
- External IDs
- MetaboliQ:condition:dao-abp1
What The Variants Change
DAO/ABP1 genotype controls are not exposed; curated variant and evidence records are required first.
No curated variant control is exposed for DAO/ABP1 in Phase 1A.
Downstream Consequences
- DAO/ABP1 context can describe extracellular histamine clearance mechanics.
- Symptom association language remains contested and not diagnostic.
- The page does not infer food tolerance, supplement use, or treatment plans.
Cross-System Connections
Approved seed-graph edges for DAO/ABP1 are pending curation. This page keeps pathway context visible without inventing factor links.
Connected pools: pending approved graph-edge curation